We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CKEC
1501
DELISTED
Carmike Cinemas Inc
CKEC
-340
Closed -$9K
TIVO
1502
DELISTED
TIVO INC
TIVO
-5,100
Closed -$67K
CIT
1503
DELISTED
CIT Group Inc.
CIT
-79,400
Closed -$4.14M
FNSR
1504
DELISTED
Finisar Corp
FNSR
-155,000
Closed -$3.71M
DGIT
1505
DELISTED
DIGITAL GENERATION INC COM STK (DE)
DGIT
-31,300
Closed -$399K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.